ArticleEuropean journal of nuclear medicine and molecular imaging2022
Determination of optimal
Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.
- Radiomics models for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.Abdominal radiology (New York) · 2022Pooled it
- Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer UndergoingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- Clinical performance of [European journal of nuclear medicine and molecular imaging · 2026Article
- Mitigating bladder signal inEJNMMI physics · 2026Article
- Enhanced data usability in dynamicEJNMMI physics · 2026Article
- Patlak-PBNT: a simple population-based Patlak model to generate [EJNMMI physics · 2026Article
- Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients.European journal of nuclear medicine and molecular imaging · 2025Article
- Dynamic FDG PET/CT imaging: quantitative assessment, advantages and application in the diagnosis of malignant solid tumors.Frontiers in oncology · 2025Review
- Combined whole-body dynamic and static PET/CT with low-dose [European journal of nuclear medicine and molecular imaging · 2024Article
- The image quality and feasibility of solitary delayed [EJNMMI research · 2024Article
- Comparison of parametric imaging and SUV imaging with [European journal of nuclear medicine and molecular imaging · 2024Article
- Enhancing PSMA PET/CT imaging of prostate cancer: investigating the impact of multiple time point evaluation, diuretic administration, cribriform pattern, and intraductal carcinoma.Annals of nuclear medicine · 2023Article
- Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography.Quantitative imaging in medicine and surgery · 2023Article
- An exploration of the feasibility and clinical value of half-dose 5-h total-bodyEuropean journal of nuclear medicine and molecular imaging · 2023Article
- Predicting the effect of different folate doses on [EJNMMI research · 2023Article
- Diagnostic value of two-time point [Scientific reports · 2023Article
- Multiparametric dynamic whole-body PSMA PET/CT using [EJNMMI research · 2023Article
- Marriage of radiotracers and total-body PET/CT rapid imaging system: current status and clinical advances.American journal of nuclear medicine and molecular imaging · 2023Review
- Article
- Current status and future perspective of radiopharmaceuticals in China.European journal of nuclear medicine and molecular imaging · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background
methodsDynamic TB-PET performed on 11 patients with prostate cancer was analyzed. TACs were obtained by drawing regions of interest in normal organs and pathological lesions (primary prostate lesions and lymph nodes and bone metastases). We evaluated the
resultsThe urinary bladder TAC increased slowly between 180 and 330 s post-injection and then rapidly between 5.5 and 60.0 min post-injection. The pathological lesion uptake increased rapidly during the first 5 min post-injection and then slowly through the remaining 55 min. Six minutes post-injection was the optimal time with the highest pathological lesion SUV
conclusionsCombining early dynamic
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.